Scientific publications
Dendritic cells, headhunters for anti-tumor CD8+ T cells in triple-negative breast cancer
Jun 9, 2023
| Magazine: Med
Carlos Luri-Rey 1, Almudena Manzanal 1, Beatrice Pinci 1, Alvaro Teijeira 2
Abstract
How do we identify patients most likely to benefit from immune checkpoint blockade therapies? This month in Med, Wu and colleagues1 identify that CCL19+ mature dendritic cells correlated with responses to anti-PD-(L)1 immunotherapy in triple-negative breast cancer patients, suggesting the use of CCL19 as a biomarker to predict patient outcomes.
CITA DEL ARTÍCULO Med. 2023 Jun 9;4(6):341-343. doi: 10.1016/j.medj.2023.05.004.
![](/.resources/ModuloCUN/resources/img/publicaciones/icono-destacado-investigadores.png)
Our authors
![Carlos Luri. Programa de Inmunología e Inmunoterapia. Cima Universidad de Navarra](/.imaging/mte/cima/profesional_carrusel-80x80/dam/cima/imagenes/profesionales/programas-transversales/inmunologia-inmunoterapia/carlos-luri/jcr:content/carlos-luri.jpg)
Carlos Luri
![Almudena Manzanal. Programa de Inmunología e Inmunoterapia. Cima Universidad de Navarra](/.imaging/mte/cima/profesional_carrusel-80x80/dam/cima/imagenes/profesionales/programas-transversales/inmunologia-inmunoterapia/saioa-arrieta-aranzueque2/jcr:content/almudena-manzanal.jpg)
Almudena Manzanal González de Lara
![Beatrice Pinci. Programa de Inmunología e Inmunoterapia. Cima Universidad de Navarra](/.imaging/mte/cima/profesional_carrusel-80x80/dam/cima/imagenes/profesionales/programas-transversales/inmunologia-inmunoterapia/untitled0/jcr:content/untitled.jpg)
Beatrice Pinci
Predoctoral
Immunology and Immunotherapy Research Program
Researcher | Principal Investigator
Research Group on Dynamics of the antitumor immune response